View performance benchmarks of the PTAB, including dispositions, pendency, inventory, and other tracking measures.
Trial Statistics
Appeal and Interference Statistics
Current FY Statistics to Date:
Current FY Statistics to Date:
Special Reports
Orange Book/Biologics Study (Jul. 2019) - a report on AIA trials involving petitions challenging Orange Book listed patents and biologic patents
Data for Orange Book/Biologics Study (Sep. 2019) - data for the Orange Book/Biologics study
Parallel Proceedings Study (Apr. 2019) - a report on interaction between parallel proceedings at the USPTO (e.g., AIA proceedings, reexam, and resissue) involving issued patents
Motion to Amend Study, Installment 5 through FY2018 (updated Mar. 2019) - a report on the outcomes of motions to amend in AIA trials
Data for 326 Completed Trials (Mar. 2019) - a report on the data for the 326 completed trials with MTA
Expanded Panels Study (Mar. 2018) - a report on panel expansion in AIA trials
Orange Book-listed Patent Study (Mar. 2018) - a report on FDA-approved drug patents challenged in AIA trials
Multiple Petition Study (Oct. 2017) - a report on multiple petitions filed in AIA trials
Contact
Email questions about PTAB Statistics to PTAB Statistics Questions